Direkt zum Inhalt

Owner only: item control page
Glutsch, Valerie ; Schummer, Patrick ; Kneitz, Hermann ; Gesierich, Anja ; Goebeler, Matthias ; Klein, Detlef ; Posch, Christian ; Gebhardt, Christoffer ; Haferkamp, Sebastian ; Zimmer, Lisa ; Becker, Jürgen C ; Leiter, Ulrike ; Weichenthal, Michael ; Schadendorf, Dirk ; Ugurel, Selma ; Schilling, Bastian

Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG

Glutsch, Valerie, Schummer, Patrick, Kneitz, Hermann, Gesierich, Anja, Goebeler, Matthias, Klein, Detlef, Posch, Christian, Gebhardt, Christoffer , Haferkamp, Sebastian, Zimmer, Lisa, Becker, Jürgen C, Leiter, Ulrike, Weichenthal, Michael , Schadendorf, Dirk, Ugurel, Selma and Schilling, Bastian (2022) Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG. Journal for ImmunoTherapy of Cancer 10 (11), e005930.

Date of publication of this fulltext: 29 Feb 2024 13:01
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleJournal for ImmunoTherapy of Cancer
Publisher:BMJ PUBLISHING GROUP
Place of Publication:LONDON
Volume:10
Number of Issue or Book Chapter:11
Page Range:e005930
Date2022
InstitutionsMedicine > Lehrstuhl für Dermatologie und Venerologie
Identification Number
ValueType
10.1136/jitc-2022-005930DOI
KeywordsOPEN-LABEL; POLYOMAVIRUS; BLOCKADE; Skin Neoplasms; CTLA-4 Antigen; Programmed Cell Death 1 Receptor; B7-H1 Antigen; Drug Therapy; Combination
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID57626

Export bibliographical data

Owner only: item control page

nach oben